The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
about
The discovery and development of romidepsin for the treatment of T-cell lymphoma.The aggressive peripheral T-cell lymphomas: 2017.Outcomes of patients with relapsed aggressive adult T-cell leukemia-lymphoma: clinical effectiveness of anti-CCR4 antibody and allogeneic hematopoietic stem cell transplantation.A new prognostic score comprising lactate dehydrogenase, albumin and neutrophil to lymphocyte ratio to predict sensitivity to first-line chemotherapy in patients with peripheral T-cell lymphomas.The risk of central nervous system relapses in patients with peripheral T-cell lymphoma.
P2860
The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
The survival outcome of patien ...... immunoblastic T-cell lymphoma.
@en
type
label
The survival outcome of patien ...... immunoblastic T-cell lymphoma.
@en
prefLabel
The survival outcome of patien ...... immunoblastic T-cell lymphoma.
@en
P2093
P2860
P356
P1476
The survival outcome of patien ...... oimmunoblastic T-cell lymphoma
@en
P2093
Chitra Hosing
Dai Chihara
Felipe Samaniego
Francesco Turturro
Fredrick B Hagemeister
Jorge E Romaguera
L Jeffrey Medeiros
Loretta J Nastoupil
Luis E Fayad
P2860
P304
P356
10.1111/BJH.14477
P407
P577
2016-12-16T00:00:00Z